Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | LSS | P48449 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.34 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12730709 | 0.86 | PARP10 (0.37) | CRBNLSSMEN1KMT2APARP10 | |
| SCHEMBL12730781 | 0.85 | PRSS1 (0.39) | MEN1KMT2AHRH3 | |
| SCHEMBL12730682 | 0.78 | LSS (0.38) | CRBNLSSHRH3 | |
| SCHEMBL12730661 | 0.77 | PARP10 (0.42) | CRBNLSSPARP10PARP15GPR119 | |
| SCHEMBL12730701 | 0.75 | RARA (0.42) | CRBNLSSPARP10PARP15GPR119 | |
| SCHEMBL16172295 | 0.74 | PARP10 (0.50) | CRBNLSSPARP10PARP15GPR119 | |
| SCHEMBL12730674 | 0.74 | THRB (0.38) | HRH3 | |
| SCHEMBL12730868 | 0.73 | ELANE (0.40) | MEN1KMT2A | |
| SCHEMBL12730761 | 0.71 | PARP15 (0.40) | MEN1KMT2APARP10PARP15 | |
| SCHEMBL13829059 | 0.70 | THRB (0.45) | CRBNLSSMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | CRBN 633/4885LSS 2763/4885MEN1 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.